Sampson, J. H., Batich, K. A., Mitchell, D. A., Herndon, J. E., Broadwater, G., Healy, P., … Friedman, A. H. (2022). Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Sampson, John H., Kristen A. Batich, Duane Anthony Mitchell, James Emmett Herndon, Gloria Broadwater, Patrick Healy, Luis Sanchez-Perez, et al. “Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Sampson JH, Batich KA, Mitchell DA, Herndon JE, Broadwater G, Healy P, et al. Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Sampson, John H., et al. “Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Sampson JH, Batich KA, Mitchell DA, Herndon JE, Broadwater G, Healy P, Sanchez-Perez L, Nair S, Congdon K, Norberg P, Weinhold KJ, Archer GE, Reap EA, Xie W, McLendon RE, Reardon DA, Vredenburgh JJ, Friedman HS, Bigner D, Friedman AH. Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. 2022.